Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA) malignancies.

被引：0
|
作者：
Turpin, Brian
Karns, Rebekah
Sarangdhar, Mayur
Weiss, Brian D.
Geller, James I.
Absalon, Michael
O'Brien, Maureen Megan
Nagarajan, Rajaram
Phillips, Christine L.
Chow, Lionel M.
DeWire, Mariko Dawn
Adams, Denise
Burns, Karen Cristly
Hummel, Trent Ryan
Fouladi, Maryam
Hammill, Adrienne Marie
Mangino, Jennifer
Pressey, Joseph Gerald
Aronow, Bruce
Perentesis, John Peter
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11011
引用
收藏
页数：1
相关论文
共 6 条
  • [1] CinCSeq: A Targeted Next-Generation Sequencing (NGS) Assay for Comprehensive Management of Pediatric, Adolescent, and Young Adult (AYA) Tumors
    Roy, S.
    Sipple, J.
    Florea, S.
    Broderick, W.
    Baum, B.
    Forcellini, J.
    Pervaiz, S.
    Yeazel, A.
    Riddle, A.
    Diorio, D.
    Picarsic, J.
    Szabo, S.
    Ranganathan, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S102 - S102
  • [2] The genomic landscape of adolescent and young adult (AYA) malignancies using DNA and RNA-based next generation sequencing.
    Lustberg, Maryam B.
    Kaneva, Kristiyana
    Teslow, Emily
    Mauer, Elizabeth
    Federman, Noah
    Eisfeld, Ann-Kathrin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS)
    Peters, Pamela
    Gonzalez, Rafael
    Havrilesky, Laura
    Berchuck, Andrew
    Strickler, John
    Green, Michelle
    Datto, Michael
    McKinney, Matthew
    Menendez, Carolyn
    Strickland, Kyle
    Previs, Rebecca
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S152 - S152
  • [4] Outcomes of surveillance in patients with intraductal papillary mucinous neoplasms (IPMNs) who tested negative for high-risk mutations (HRMs) in next-generation sequencing (NGS).
    Kannan, Amudhan
    Murimwa, Gilbert Zvikomborero
    Mansour, John C.
    Ellis, Daniel
    Sawas, Tarek
    Vanderveldt, Hendrikus Dutch
    Foley, Samantha Blake
    Coleman, Veronica
    Rajamohan, Naveen
    Khatri, Gaurav
    Fleming, Jason B.
    Zeh, Herbert J.
    Kubiliun, Nisa
    Polanco, Patricio M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 704 - 704
  • [5] Factors Associated with High-Risk Mutations in Cyst Fluid Next Generation Sequencing (NGS) in Patients with Small Intraductal Papillary Mucinous Neoplasms (2-3 cm): A Multicenter Study
    Kannan, Amudhan
    Sawas, Tarek
    Kubiliun, Nisa
    Mansour, John C.
    Zureikat, Amer H.
    Zeh, Herbert J., III
    Singhi, Aatur D.
    Polanco, Patricio M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S443 - S443
  • [6] Whether Detection of Gene Mutations Could Identify Low- or High-Risk Papillary Thyroid Microcarcinoma? Data from 393 Cases Using the Next-Generation Sequencing
    Jin, Lei
    Zhou, Liang
    Wang, Jian-Biao
    Tao, Li
    Lu, Xiao-Xiao
    Yan, Na
    Chen, Qian-Ming
    Cao, Li-Ping
    Xie, Lei
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
1